Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronique V Belzil

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Acta Neuropathologica|June 11, 2016
ALS and FTD: an epigenetic perspectiveVeronique V Belzil, Rebecca B Katzman, Leonard Petrucelli
Molecular and Cellular Neurosciences|January 3, 2013
RNA-mediated toxicity in neurodegenerative diseaseVeronique V Belzil, Tania F Gendron, Leonard Petrucelli
Advances in Neurobiology|June 20, 2018
An Epigenetic Spin to ALS and FTDMark T W Ebbert, Rebecca J Lank, Veronique V Belzil
Acta Neuropathologica|January 8, 2014
Mechanisms of toxicity in C9FTLD/ALSTania F Gendron, Veronique V Belzil, Yong-Jie Zhang, et al.
Archives of Neurology|January 18, 2012
Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosisVeronique V Belzil, Jean-Sébastien Langlais, Hussein Daoud, et al.
Brain Research|February 18, 2014
Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patientsVeronique V Belzil, Peter O Bauer, Tania F Gendron, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 26, 2024
Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United StatesErica Engelberg-Cook, Jaimin S Shah, Andre Teixeira da Silva Hucke, et al.
Journal of Extracellular Vesicles|September 23, 2025
TurboID-Mediated Profiling of Glioblastoma-Derived Extracellular Vesicle Cargo ProteinsMarissa N Russo, Emily S Norton, Maria José Ulloa-Navas, et al.
Annals of Human Genetics|October 23, 2009
A mutation that creates a pseudoexon in SOD1 causes familial ALSPaul N Valdmanis, Veronique V Belzil, James Lee, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Acta Neuropathologica|June 11, 2016
ALS and FTD: an epigenetic perspectiveVeronique V Belzil, Rebecca B Katzman, Leonard Petrucelli
Molecular and Cellular Neurosciences|January 3, 2013
RNA-mediated toxicity in neurodegenerative diseaseVeronique V Belzil, Tania F Gendron, Leonard Petrucelli
Advances in Neurobiology|June 20, 2018
An Epigenetic Spin to ALS and FTDMark T W Ebbert, Rebecca J Lank, Veronique V Belzil
Acta Neuropathologica|January 8, 2014
Mechanisms of toxicity in C9FTLD/ALSTania F Gendron, Veronique V Belzil, Yong-Jie Zhang, et al.
Archives of Neurology|January 18, 2012
Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosisVeronique V Belzil, Jean-Sébastien Langlais, Hussein Daoud, et al.
Brain Research|February 18, 2014
Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patientsVeronique V Belzil, Peter O Bauer, Tania F Gendron, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 26, 2024
Prognostic Factors and Epidemiology of Amyotrophic Lateral Sclerosis in Southeastern United StatesErica Engelberg-Cook, Jaimin S Shah, Andre Teixeira da Silva Hucke, et al.
Journal of Extracellular Vesicles|September 23, 2025
TurboID-Mediated Profiling of Glioblastoma-Derived Extracellular Vesicle Cargo ProteinsMarissa N Russo, Emily S Norton, Maria José Ulloa-Navas, et al.
Annals of Human Genetics|October 23, 2009
A mutation that creates a pseudoexon in SOD1 causes familial ALSPaul N Valdmanis, Veronique V Belzil, James Lee, et al.
Experimental Neurology|January 10, 2016
C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cellsRustam Esanov, Kinsley C Belle, Marka van Blitterswijk, et al.
Pageof 3